Vanguard Investments Australia
KURA icon

Vanguard Investments Australia’s Kura Oncology KURA Stock Holding History

Vanguard Investments Australia’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Hold
25,474
– – ﹤0.01% 1959
2026
Q1 		$207K Buy
+25,474
New +$219K ﹤0.01% 2018

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Vanguard Investments Australia's KURA Position: Q2 2026 in Review

Vanguard Investments Australia held its Kura Oncology (KURA) position steady in Q2 2026 at 25,474 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

Vanguard Investments Australia first reported a position in KURA in Q1 2026 and has held it in 2 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Vanguard Investments Australia held 25,474 shares of Kura Oncology worth $279K as of Q2 2026.
  • Vanguard Investments Australia left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1959 holding.
  • Vanguard Investments Australia first reported a position in Kura Oncology in Q1 2026 and has held it in 2 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.